A5064996258- Antifungal resistance and susceptibility
- Fungal Infections and Studies
- Plant Pathogens and Fungal Diseases
- Infectious Diseases and Mycology
- Pneumocystis jirovecii pneumonia detection and treatment
- Nail Diseases and Treatments
- Mycotoxins in Agriculture and Food
- Fungal Biology and Applications
- Neutropenia and Cancer Infections
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- Peptidase Inhibition and Analysis
- Bacterial Identification and Susceptibility Testing
- Complement system in diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- HIV Research and Treatment
- Nosocomial Infections in ICU
- Cystic Fibrosis Research Advances
- Infection Control in Healthcare
- Medical Device Sterilization and Disinfection
- Transplantation: Methods and Outcomes
- Immune Cell Function and Interaction
- Helminth infection and control
- COVID-19 Clinical Research Studies
- Parasitic Diseases Research and Treatment
Innsbruck Medical University
2016-2025
Universität Innsbruck
2016-2025
Christian Doppler Klinik
2017-2022
Assistance Publique – Hôpitaux de Paris
2022
Université Paris Cité
2022
Statens Serum Institut
2012-2020
Ospedale Policlinico San Martino
2020
European Society of Intensive Care Medicine
2020
Clinical Research Consortium
2020
First Pavlov State Medical University of St. Petersburg
2019
The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy various types of infection patients with hematologic malignancies hematopoietic stem cell transplantation recipients. Meetings are held every two years since 2005 evidence-based elaborated after evaluation the literature discussion among specialists nearly all countries. In this manuscript, ECIL group presents 2015-update treatment...
Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of influenza-associated (IAPA) using current definitions for invasive fungal diseases has proven difficult, and our aim was develop case IAPA that can facilitate clinical studies. A group 29 international experts reviewed insights into epidemiology, diagnosis management proposed a definition through process informal consensus. Since may wide range...
To investigate azole resistance in clinical Aspergillus isolates, we conducted prospective multicenter international surveillance. A total of 3,788 isolates were screened 22 centers from 19 countries. Azole-resistant A. fumigatus was more frequently found (3.2% prevalence) than previously acknowledged, causing resistant invasive and noninvasive aspergillosis severely compromising use azoles.
Oral triazole therapy is well established for the treatment of invasive (IPA), allergic (ABPA), and chronic pulmonary (CPA) aspergillosis, often long-term. Triazole resistance rates are rising internationally. Microbiological diagnosis aspergillosis limited by poor culture yield, leading to uncertainty about frequency resistance.